Director of Data Science for Real World Evidence #3325

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on reducing the global impact of cancer by developing innovative technology to detect and identify various deadly types of cancer early. The company uses the power of next-generation sequencing, large-scale clinical studies, and cutting-edge computer science and data science to enhance the scientific understanding of cancer biology, and to develop its multi-cancer early detection blood test. GRAIL is based in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom. GRAIL, LLC is a fully owned subsidiary of Illumina, Inc. (NASDAQ:ILMN). For more information, please visit .